Aflibercept in Diabetic Macular Oedema Previously Refractory to Standard Intravitreal Therapy: An Irish Retrospective Study

INTRODUCTION: To determine visual and anatomical outcomes of diabetic macular oedema (DMO) patients in a tertiary centre following conversion to aflibercept having been refractory to previous treatment with bevacizumab/ranibizumab. METHODS: A retrospective case series of patients with a diagnosis of...

Descripción completa

Detalles Bibliográficos
Autores principales: McCloskey, Clare F., Mongan, Ann-Marie, Chetty, Shivona, McAteer, Darren M. J., Quinn, Shauna M.
Formato: Online Artículo Texto
Lenguaje:English
Publicado: Springer Healthcare 2018
Materias:
Case Series
Acceso en línea:https://www.ncbi.nlm.nih.gov/pmc/articles/PMC5997601/
https://www.ncbi.nlm.nih.gov/pubmed/29508370
http://dx.doi.org/10.1007/s40123-018-0123-0

Internet

https://www.ncbi.nlm.nih.gov/pmc/articles/PMC5997601/
https://www.ncbi.nlm.nih.gov/pubmed/29508370
http://dx.doi.org/10.1007/s40123-018-0123-0

Ejemplares similares